# Lunai Bioworks

Type: Company (LNAI)

Source: Startup Intelligence Brief — https://getstartupbrief.com/entity/lunai-bioworks
Canonical HTML page: https://getstartupbrief.com/entity/lunai-bioworks

## Timeline

- **2029-03**: Cycle Completion — Target completion for the first 3-year development cycle under the new model.
- **2027-Q1**: First Milestone — Anticipated first-round validation of AI-modeled antidote candidates.
- **2026-Q3**: Bidding Window — Expected commencement of bidding for initial U.S. countermeasure contracts.
- **2026-03-19**: Consortium Launch — Lunai Bioworks officially establishes the National Chemical Defense Consortium.

## Recent coverage (1 stories)

### Lunai Bioworks Launches AI Consortium for $1.2B U.S. Chemical Defense
2026-03-19 16:33:27 · Sentiment: Positive · Impact: 7/10 · Sources: 2

Lunai Bioworks (NASDAQ: LNAI) has established the National Chemical Defense Consortium to secure up to $1.2 billion in U.S. government countermeasure contracts. The initiative centers on a proprietary three-year AI-driven model designed to accelerate the development of chemical antidotes.
Full story: https://getstartupbrief.com/story/lunai-bioworks-chemical-defense-consortium-ai-antidote

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getstartupbrief.com/guides/methodology for the full editorial methodology.